Pharmaceutical compositions comprising maralixibat and uses thereof
AssigneeMirum Pharmaceuticals, Inc.
InventorParag VED
Life of this patent
Estimating the term…
Abstract
The invention relates to a pharmaceutical composition comprising maralixibat, or a pharmaceutically acceptable salt thereof, as the active ingredient. The invention further relates to the use of the pharmaceutical composition as a solid dosage drug product. The invention also relates to the use of the pharmaceutical composition and the solid dosage drug product described herein for treating cholestatic pruritus and cholestatic liver disease.
Claims22
-170. (canceled)
A method of treating cholestatic pruritus in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising maralixibat, or a pharmaceutically acceptable salt thereof, and:
- (i) a lubricant selected from the group consisting of magnesium stearate, talc, calcium stearate, zinc stearate, sodium stearate, sodium stearyl fumarate, sodium lauryl sulfate, stearic acid, aluminum stearate, leucine, glyceryl behenate, glyceryl dibehenate, glyceryl palmitostearate, hydrogenated vegetable oil, and any combinations thereof, in an amount of about 6% to about 12% (w/w);
- and
- (ii) a disintegrant selected from the group consisting of croscarmellose sodium, crospovidone, starch, sodium starch glycolate, and any combinations thereof, in an amount of about 1% to about 10% (w/w).
A method of treating cholestatic pruritus in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a pharmaceutical dosage form comprising about 5 mg to about 50 mg maralixibat, or a pharmaceutically acceptable salt thereof, based on the free base weight of maralixibat and:
- (iii) a lubricant selected from the group consisting of magnesium stearate, talc, calcium stearate, zinc stearate, sodium stearate, sodium stearyl fumarate, sodium lauryl sulfate, stearic acid, aluminum stearate, leucine, glyceryl behenate, glyceryl dibehenate, glyceryl palmitostearate, hydrogenated vegetable oil, and any combinations thereof, in an amount of about 6% to about 12% (w/w);
- and
- (iv) a disintegrant selected from the group consisting of croscarmellose sodium, crospovidone, starch, sodium starch glycolate, and any combinations thereof, in an amount of about 1% to about 10% (w/w).
Dependencies are inferred from the claim text.